ID   CMeC-1
AC   CVCL_L326
SY   CMeC1; C1
DR   Wikidata; Q54813755
RX   PubMed=15585963;
RX   PubMed=28283079;
CC   Doubling time: 37.7 +- 3.44 hours (PubMed=15585963).
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: Chow; VBO=VBO_0200361.
DI   NCIt; C120298; Canine melanoma
OX   NCBI_TaxID=9615; ! Canis lupus familiaris (Dog)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 13
CH   CVCL_L327 ! CMeC-2
//
RX   PubMed=15585963; DOI=10.1292/jvms.66.1437;
RA   Inoue, Kaori
RA   Ohashi, Emi
RA   Kadosawa, Tsuyoshi
RA   Hong, Sung-Hyeok
RA   Matsunaga, Satoru
RA   Mochizuki, Manabu
RA   Nishimura, Ryohei
RA   Sasaki, Nobuo
RT   "Establishment and characterization of four canine melanoma cell
RT   lines.";
RL   J. Vet. Med. Sci. 66:1437-1440(2004).
//
RX   PubMed=28283079; DOI=10.1016/j.tvjl.2017.02.001;
RA   Yoshitake, Ryohei
RA   Saeki, Kohei
RA   Watanabe, Matanobu
RA   Nakaoka, Nanako
RA   Ong, Siew Mei
RA   Hanafusa, Masakazu
RA   Choisunirachon, Nan
RA   Fujita, Naoki
RA   Nishimura, Ryohei
RA   Nakagawa, Takayuki
RT   "Molecular investigation of the direct anti-tumour effects of
RT   nonsteroidal anti-inflammatory drugs in a panel of canine cancer cell
RT   lines.";
RL   Vet. J. 221:38-47(2017).
//